A patient with systemic lupus erythematosus (SLE)-related insulin resistance was successfully treated with cyclophosphamide plus mycophenolate mofetil

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1388, 2003-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Study of Mycophenolate Mofetil in Patients with Systemic Lupus Erythematosus and Design of Bayesian Estimator Using Limited Sampling Strategies

By Zahr Noël  

Clinical Pharmacokinetics, Vol. 47, Iss. 4, 2008-01 ,pp. : 277-284

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials

By Liu Lin-Lin  

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1521-1533

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil a promising alternative in lupus

By  

Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil has potential in refractory SLE

By  

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 2, 2008-03 ,pp. : 134-136

Bentham Science Publishers

Access to resources Recommend Favorite